Banned Drugs Worth Rs 5.7crore Seized In Rampur, 11 Arrested

Bareilly : Police in Rampur district have arrested 11 people and allegedly recovered from their possession banned drugs worth Rs 5.7 crore. All the accused were sent to jail on Saturday.

According to police, during a routine checking drive at a check-post in Shahzadnagar area a man, riding a motorcycle, was asked to stop. But he sped away.

A team chased him and managed to stop him. Some sedative drugs were recovered from his possession. During interrogation, he revealed that the gang members were running a business of selling sedative drugs in various UP districts.

It was then that the gang was busted. It was operating from a building in Durgnagala village.

Superintendent of police, Rampur, Ankit Mittal said, “Eleven people involved in the business of selling sedative drugs were  arrested. Drugs worth Rs 5.7 crore were recovered from their possession.”

  • Related Posts

    Commissioner FDA reviews enforcement measures

    Srinagar: Commissioner, Food & Drugs Administration (FDA), Jammu & Kashmir, Khalid Jahangir on Thursday held an introductory meeting with senior officers and field functionaries of Drug and Food Wing of the…

    Karnataka High Court stays FSSAI advisory banning use of Ashwagandha leaves in health supplements

    Karnataka High Court Ashwagandha ruling offers interim relief to supplement makers challenging the FSSAI advisory on Ashwagandha extracts. The Karnataka High Court has stayed an advisory issued by the Food…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Commissioner FDA reviews enforcement measures

    Commissioner FDA reviews enforcement measures

    Karnataka High Court stays FSSAI advisory banning use of Ashwagandha leaves in health supplements

    Karnataka High Court stays FSSAI advisory banning use of Ashwagandha leaves in health supplements

    Roche Pharma launches Tecentriq® SC, India’s first subcutaneous immunotherapy for lung cancer

    Roche Pharma launches Tecentriq® SC, India’s first subcutaneous immunotherapy for lung cancer

    CDSCO tighten drug quality oversight as substandard and spurious medicine cases rise in five years

    CDSCO tighten drug quality oversight as substandard and spurious medicine cases rise in five years

    Piramal Pharma Gets 3 USFDA Observations at US Facility

    Piramal Pharma Gets 3 USFDA Observations at US Facility

    Eli Lilly pauses Indian obesity awareness campaign after regulatory notices

    Eli Lilly pauses Indian obesity awareness campaign after regulatory notices